People: Transition Therapeutics Inc (TTH.TO)

TTH.TO on Toronto Stock Exchange

6.90CAD
23 Jul 2014
Price Change (% chg)

$0.10 (+1.47%)
Prev Close
$6.80
Open
$6.78
Day's High
$6.91
Day's Low
$6.78
Volume
1,420
Avg. Vol
2,880
52-wk High
$9.25
52-wk Low
$3.99

Search Stocks

Rusaw, Nicole 

Brief Biography

Ms. Nicole Rusaw, C.A., is Chief Financial Officer of Transition Therapeutics Inc. Ms. Rusaw has been with the Company since 2005 and was appointed as Chief Financial Officer in December 2011. While at Transition, Ms. Rusaw has been responsible for a broad range of activities with a focus on financial reporting and regulatory compliance as well as involvement in various equity financings and strategic acquisitions.

Basic Compensation

Total Annual Compensation, CAD Long-Term Incentive Plans, CAD All Other, CAD Fiscal Year Total, CAD
222,480 -- 93,574 316,054

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Tony Cruz

706,308

Nicole Rusaw

316,054

Carl Damiani

319,775

Bruce Connop

287,182

Aleksandra Pastrak

407,711

Louis Alexopoulos

--
As Of 29 Jun 2013
Search Stocks